Safety Monitoring of Disease-Modifying Therapies in Multiple

Name: Safety Monitoring of Disease-Modifying Therapies in Multiple Sclerosis
Uploaded: 2024-05-02T21:03:32+00:00
Description: Aisha Elfasi, MD, Clinical and Research Fellow, Department of Neurology, Johns Hopkins University, provides an overview of the currently available disease-

Media formats available:

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

MS Minute: Update on BTK Inhibitors for Multiple Sclerosis—A New Treatment That Brings New Hope
MS Minute: Update on BTK Inhibitors for Multiple Sclerosis—A New Treatment That Brings New Hope
MS & Immune Disorders
MS Minute: Update on BTK Inhibitors for Multiple Sclerosis—A New Treatment That Brings New Hope
Brett Graham, MD; Robert J. Fox, MD
Brett Graham, MD; Robert J. Fox, MD
Microplastics and "Negative Neuroplasticity": An Emerging Topic in Clinical Neurology
Microplastics and "Negative Neuroplasticity": An Emerging Topic in Clinical Neurology
Practice Management
Microplastics and "Negative Neuroplasticity": An Emerging Topic in Clinical Neurology
Keshav Shah, MBBS; David A. Davis, PhD
Keshav Shah, MBBS; David A. Davis, PhD
Learning, Laughing, and Living with Multiple Sclerosis
Learning, Laughing, and Living with Multiple Sclerosis
MS & Immune Disorders
Learning, Laughing, and Living with Multiple Sclerosis
Ardra Shephard; Jiwon Oh, MD, PhD, FRCPC
Ardra Shephard; Jiwon Oh, MD, PhD, FRCPC
Neuro-Ophthalmology Notions: Retinal Artery Occlusion—Diagnosis and Treatment Considerations
Neuro-Ophthalmology Notions: Retinal Artery Occlusion—Diagnosis and Treatment Considerations
MS & Immune Disorders
Neuro-Ophthalmology Notions: Retinal Artery Occlusion—Diagnosis and Treatment Considerations
Rachel Aubert, DO; Sergio Garces, MD
Rachel Aubert, DO; Sergio Garces, MD